Barclays raised the firm’s price target on Allstate (ALL) to $187 from $175 and keeps an Underweight rating on the shares. The company’s operating earnings well above estimates on strong Property-Liability results, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALL:
- Allstate reports Q3 adjusted EPS $3.91, consensus $2.43
- ALL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Allstate price target lowered to $207 from $210 at Goldman Sachs
- Allstate price target raised to $233 from $216 at BofA
- Allstate price target raised to $214 from $205 at BMO Capital